MetaCap

SpyGlass Pharma (SGP) vs vVARDIS (VVVV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

SpyGlass Pharma is the larger company by market cap ($1.02 billion vs $770.9 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SGP-7.45%VVVV-11.82%
+1%-6%-12%
Nov 13, 20261 yearNov 20, 2026
SGP-7.45%VVVV-11.82%
+1%-6%-12%
Nov 9, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SGP versus VVVV key metrics
MetricSGPVVVV
Share price$30.43$14.55
Market cap$1.02B$770.91M
1-day change-1.14%-3.00%
EPS (TTM)$-2.70$-0.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-39.87M—
52-week high$39.92$16.95
52-week low$17.06$14.00
Distance from 52-week high-23.77%-14.16%
Analyst consensusstrong_buy—
Avg. price target upside+53.37%—
Average volume114.63K963.08K
Shares outstanding33.46M38.59M
Employees88153
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About SpyGlass Pharma

SGP stock →

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.

Health Care · Medical/Dental Instruments · 88 employees

About vVARDIS

VVVV stock →

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.

Health Care · Medical/Dental Instruments · 153 employees

SGP vs VVVV FAQ

Which is bigger, SpyGlass Pharma or vVARDIS?

SpyGlass Pharma (SGP) is larger, with a market capitalization of $1.02B compared with $770.91M for vVARDIS (VVVV).

Are SpyGlass Pharma and vVARDIS in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons